MedTrace Logo

Mast Cell Connect: A Registry for Patients With Mastocytosis

NCT02620254 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 743

Last updated 2021-02-04

No results posted yet for this study

Summary

The Mast Cell Connect Registry is a voluntary, observational database that will capture demographic, socioeconomic, and disease information directly from patients with mastocytosis via a secure web-based tool. No experimental intervention is involved.

Conditions

  • Mastocytosis

Sponsors & Collaborators

  • PatientCrossroads

    collaborator INDUSTRY

  • Blueprint Medicines Corporation

    lead INDUSTRY

Principal Investigators

  • Anthony L Boral, MD, PhD · Blueprint Medicines Corporation

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2021-01-31
Completion
2021-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02620254 on ClinicalTrials.gov